245 related articles for article (PubMed ID: 19684613)
1. Nuclear EGFR contributes to acquired resistance to cetuximab.
Li C; Iida M; Dunn EF; Ghia AJ; Wheeler DL
Oncogene; 2009 Oct; 28(43):3801-13. PubMed ID: 19684613
[TBL] [Abstract][Full Text] [Related]
2. Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Iida M; Bahrar H; Brand TM; Pearson HE; Coan JP; Orbuch RA; Flanigan BG; Swick AD; Prabakaran PJ; Lantto J; Horak ID; Kragh M; Salgia R; Kimple RJ; Wheeler DL
Mol Cancer Ther; 2016 Sep; 15(9):2175-86. PubMed ID: 27422810
[TBL] [Abstract][Full Text] [Related]
3. Rhamnose modified antibodies show improved immune killing towards EGFR-positive solid tumor cells.
Hong H; Zhao J; Zhou K; Li Y; Li D; Wu Z
Carbohydr Res; 2024 Feb; 536():109038. PubMed ID: 38219633
[TBL] [Abstract][Full Text] [Related]
4. Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation.
Nozaki M; Yasui H; Ohnishi Y
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31615015
[TBL] [Abstract][Full Text] [Related]
5. Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors.
Egloff AM; Grandis JR
J Oncol; 2009; 2009():896407. PubMed ID: 19636423
[TBL] [Abstract][Full Text] [Related]
6. Nuclear EGFR as a molecular target in cancer.
Brand TM; Iida M; Luthar N; Starr MM; Huppert EJ; Wheeler DL
Radiother Oncol; 2013 Sep; 108(3):370-7. PubMed ID: 23830194
[TBL] [Abstract][Full Text] [Related]
7. Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells.
Huang WC; Chen YJ; Li LY; Wei YL; Hsu SC; Tsai SL; Chiu PC; Huang WP; Wang YN; Chen CH; Chang WC; Chang WC; Chen AJ; Tsai CH; Hung MC
J Biol Chem; 2011 Jun; 286(23):20558-68. PubMed ID: 21487020
[TBL] [Abstract][Full Text] [Related]
8. EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.
Liccardi G; Hartley JA; Hochhauser D
Cancer Res; 2011 Feb; 71(3):1103-14. PubMed ID: 21266349
[TBL] [Abstract][Full Text] [Related]
9. Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor.
Iida M; Brand TM; Campbell DA; Li C; Wheeler DL
Oncogene; 2013 Feb; 32(6):759-67. PubMed ID: 22430206
[TBL] [Abstract][Full Text] [Related]
10. COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport.
Wang YN; Wang H; Yamaguchi H; Lee HJ; Lee HH; Hung MC
Biochem Biophys Res Commun; 2010 Sep; 399(4):498-504. PubMed ID: 20674546
[TBL] [Abstract][Full Text] [Related]
11. Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.
Montagut C; Dalmases A; Bellosillo B; Crespo M; Pairet S; Iglesias M; Salido M; Gallen M; Marsters S; Tsai SP; Minoche A; Seshagiri S; Serrano S; Himmelbauer H; Bellmunt J; Rovira A; Settleman J; Bosch F; Albanell J
Nat Med; 2012 Jan; 18(2):221-3. PubMed ID: 22270724
[TBL] [Abstract][Full Text] [Related]
12. Understanding resistance to EGFR inhibitors-impact on future treatment strategies.
Wheeler DL; Dunn EF; Harari PM
Nat Rev Clin Oncol; 2010 Sep; 7(9):493-507. PubMed ID: 20551942
[TBL] [Abstract][Full Text] [Related]
13. Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2.
Wang YN; Lee HH; Lee HJ; Du Y; Yamaguchi H; Hung MC
J Biol Chem; 2012 May; 287(20):16869-79. PubMed ID: 22451678
[TBL] [Abstract][Full Text] [Related]
14. The nuclear epidermal growth factor receptor signaling network and its role in cancer.
Brand TM; Iida M; Li C; Wheeler DL
Discov Med; 2011 Nov; 12(66):419-32. PubMed ID: 22127113
[TBL] [Abstract][Full Text] [Related]
15. Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer.
Nguyen PT; Shimojukkoku Y; Kajiya Y; Oku Y; Tomishima A; Shima K; Sasahira T
PLoS One; 2024; 19(5):e0300446. PubMed ID: 38820302
[TBL] [Abstract][Full Text] [Related]
16. YES1 as a potential target to overcome drug resistance in EGFR-deregulated non-small cell lung cancer.
Kook E; Lee J; Kim DH
Arch Toxicol; 2024 May; 98(5):1437-1455. PubMed ID: 38443724
[TBL] [Abstract][Full Text] [Related]
17. Nuclear translocation of Axl contributes to the malignancy of oral cancer cells.
Su YF; Shen PC; Huang WY; Hung YJ; Huang TW; Lin CY; Shieh YS
J Dent Sci; 2024 Jan; 19(1):438-447. PubMed ID: 38303797
[TBL] [Abstract][Full Text] [Related]
18. Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance.
Santi MD; Zhang M; Liu N; Viet CT; Xie T; Jensen DD; Amit M; Pan H; Ye Y
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004424
[TBL] [Abstract][Full Text] [Related]
19. Advances in PET/CT Imaging for Breast Cancer.
de Jong D; Desperito E; Al Feghali KA; Dercle L; Seban RD; Das JP; Ma H; Sajan A; Braumuller B; Prendergast C; Liou C; Deng A; Roa T; Yeh R; Girard A; Salvatore MM; Capaccione KM
J Clin Med; 2023 Jul; 12(13):. PubMed ID: 37445572
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
